key: cord-0717685-go5hscdu
authors: Collaço, Nicole; Legg, Julian; Day, Maria; Culliford, David; Campion, Anna; West, Carolyn; Darlington, Anne‐Sophie
title: COVID‐19: Impact, experiences, and support needs of children and young adults with cystic fibrosis and parents
date: 2021-06-29
journal: Pediatr Pulmonol
DOI: 10.1002/ppul.25537
sha: c8a000081ad1a3035fc525a7b99092e433c3fdc0
doc_id: 717685
cord_uid: go5hscdu

BACKGROUND: Little is known about the impact of COVID‐19 and the United Kingdom's (UK) national shielding advice on people with cystic fibrosis (CF) and their families. This study explored the experiences and support needs of children and young adults (CYAs) with CF, and parents who have a child with CF, during the COVID‐19 pandemic. METHODS: CYAs with CF and parents of CYAs with CF completed a UK wide online survey with open and closed questions exploring experiences, information and support needs and decision‐making processes. Qualitative thematic content analysis and descriptive quantitative analyses were undertaken. RESULTS: CYAs aged 10–30 years (n = 99) and parents of CYAs aged 0–34 years (n = 145) responded. Parents (72.7%) and CYAs (50.0%) worried about the virus, and both were vigilant for virus symptoms (82.7% and 79.7%). Over three‐quarters of CYAs were worried about their own health if they caught the virus. CYAs worried about feeling more isolated during the virus (64.9%). Qualitative findings reported the following themes: (1) Disruption—caused by isolation, (2) impact on psychological wellbeing, (3) safety of shielding, and (4) healthcare and treatment provision—changes to care, access and support. CONCLUSIONS: The impact of COVID‐19 and UK shielding advice to have no contact with anyone outside the household caused disruption to the lives and routines of individuals in relation to work, education, social lives, relationships, CF management routines and support. Parents and CYAs highlighted the need for clear, up‐to‐date and tailored advice on individualized risks and shielding.

The COVID-19 (SARS-CoV-2) pandemic has had a global impact on healthcare facilities, economy and psychosocial life. Whilst children and young adults (CYAs) comprise only 1%-2% of cases of COVID-19 worldwide, [1] [2] [3] and seem to have a lower risk of infection than adults 4 ; the virus and its impact has caused significant worry and anxiety for children with serious conditions and their parents. 5, 6 Infection with SARS-CoV-2 primarily causes respiratory illness ranging from mild disease to severe life-threatening acute respiratory distress syndrome. 7 Respiratory viral infection in cystic fibrosis (CF) patients is associated with acute pulmonary exacerbations and typically cause significantly greater morbidity than in non-CF individuals. 8 Consequently, during the initial stages of the pandemic, it was presumed that individuals with CF would be particularly vulnerable to infection with SARS-CoV-2 with a high risk of serious illness. 5 However, subsequent data established that infection gave rise to a similar spectrum of outcomes to that seen in the general population with a more severe clinical course associated with older age, CF-related diabetes, lower lung function in the year before infection and having received an organ transplant. 9 A further international observational study on the clinical characteristics of SARS-CoV-2 in 105 children with CF across 13 countries (infants to adolescents) found that infection in children with CF is usually associated with a mild illness in those without pre-existing severe lung disease. 10 Several characteristics of CF airway pathophysiology have been proposed which may abrogate the severity of COVID-19 in CF. These include altered autophagy (required for SARS-CoV-2 replication), increased levels of serine protease inhibitor (reducing SARS-CoV-2 entry into epithelial cells) and elevated ACE2 (leading to increased conversion of pro-inflammatory angiotensin II to anti-inflammatory angiotensin-1-7). 11, 12 The baseline incidence of anxiety and depression is elevated in individuals with CF and their parents. 13 Research has demonstrated that individuals with CF and their families experience high rates of clinically significant symptoms of depression and anxiety [14] [15] [16] compared with community samples. 17, 18 There is also increasing evidence of the significant psychological impact of the COVID-19 pandemic on individuals with CF. A Belgian study assessed the impact of COVID-19 on emotional wellbeing of patients with CF (mean age 32.2 years) and parents of children with CF (mean age 39.4 years); reporting increased stress, fear and worry about CF and the future. 19 Two further studies have evaluated the impact of COVID-19 on anxiety in children with CF 20,21 and their mothers 21 reporting increased anxiety primarily amongst mothers of children with CF as well as those with non CF children compared to children with CF. 20, 21 The UK government initially considered children and young adults with CF to be clinically extremely vulnerable to COVID-19 and recommended "shielding"-that is, to remain at home at all times and have no face to face contact with anyone outside of their household, except to attend to medical needs. 22 Information regarding the pandemic is constantly evolving and families are continually having to assess the information they receive from multiple potential sources in relation to COVID-19 and make decisions accordingly. Whilst previous studies have focused on the psychological impact of COVID-19 on children and their families, [19] [20] [21] we utilised a UK wide online survey to explore the pandemic's wider impact in relation to the impact of restrictions such as "shielding," parents' views on school attendance, decision-making related to the virus and perceived information and support needs.

A survey study was conducted on CYAs with CF (ages 10-30 years) and parents/carers of CYAs with CF. The survey assessed views and experiences, information and support needs, decision making, shielding, exercise and treatment. We developed this survey with input from CYAs, parents, clinicians, youth workers and patient advocacy groups, and their involvement took place from study design to piloting of the survey. This survey is part of a larger longitudinal study assessing the experiences of CYAs with serious pediatric medical conditions and their parents. 6 We collected surveys between May and July 2020. This time period encompassed the first UK "national lockdown" as well as a period when restrictions were eased.

The study was approved by the University of Southampton and UK NHS Health Research Authority Ethics Committees (IRAS nr. 282176).

Parents of a CYA with CF and CYAs with CF aged between 10 and 30 years who were able to read and respond in English were invited to take part in the survey. We recruited participants through the Southampton pediatric and adult service by email and through a national CF charity (The Cystic Fibrosis Trust) using their website and targeted closed Facebook group page. Electronic consent was obtained before completing the online survey. The aim was to recruit approximately 150-200 respondents to ensure sufficient numbers of participants to identify the range of issues and experiences, 23 

The survey content was informed by available literature [26] [27] [28] Demographic information (age, treatment, ethnicity) was also collected (see Table 1 ).

We carried out descriptive statistics using IBM Statistical Package for Social Science (SPSS) to summarize demographic data and descriptive statistics of closed item statements (collapsing the lowest two response options Not at all, A little and the highest two response options Quite a bit, Very much into a binary outcome).

Thematic content analysis was conducted on the free text data, and informed by a three stage coding process 29, 30 : (1) We openly coded initial responses into broad comment categories (NC, MD, JL), refining the framework, and resolving any conflicts with another researcher (ASD); stage 2) the framework was used to categorize all responses from the data, with further refinement after discussion as a team (NC, MD, JL, ASD); stage 3) overarching themes were identified from the analysis of content between categories. Number of comments were counted to identify weight of themes. The total number of comments does not match the number of participants due to overlaps in comments to categories.

One hundred and forty-five parents responded to the survey of which 88.3% (n = 128) were mothers, 11.0% (n = 16) were fathers and 0.7% (n = 1) foster carer. The majority of parent respondents 96.6% (n = 140) were White. The median age of the CYAs of responding parents was 9

years. The majority of respondents were from England 88.3% (n = 128).

Ninety-nine CYAs responded to the survey and the majority of CYAs 91.9% (n = 91) were White. The median age of CYAs completing the survey was 24 years old. Respondents were predominantly located in England, 75.8% (n = 75). Table 1 summarizes respondents' characteristics. 

The study generated quantitative results from the closed statement items. These are presented for parents ( Figure 1 ) and CYAs ( Figure 2 ) as numbers and percentage of total that responded "Quite a bit" and "Very much" to each statement. To avoid replication of findings, the themes from the "Experiences" open text box are described below and presented with additional quotes in Table 2 (see online Supporting Information file) .

Four main themes were identified: disruption, impact on psychological wellbeing, safety of shielding, and healthcare and treatment provision.

The lives of parents and CYAs were significantly disrupted due to lockdown and shielding. Many parents and CYAs reported missing social engagements/support, education, and their work life:

It's also been hard on us as a family because we′ve not been able to lean on our family as we would want to for support, nor have they been able to hold and cuddle her. She's changing so much and everyone around us is missing out on these precious times (Parent).

Shielding impacted upon future plans for some individuals with CF who were due to start university, or enter employment: Some CYAs were anxious or worried about returning to work and even leaving the house after being advised to shield for a long time:

[…] as soon as we are allowed to go back to normality and I have to return to work, this is what scares me and I will get a lot of anxiety […]

(CYA, 30 years). The qualitative findings highlighted that families faced significant challenges in relation to the advice to maintain complete isolation.

Although shielding provided a safety net for some individuals, for many there was a negative impact on their psychological wellbeing.

Psychologists working in CF teams have an important role to play in talking through these concerns, helping families identify adaptive coping strategies and offering psychological therapy to those experiencing longer term difficulties. The increased use of video appointments has enabled psychologists working with people with CF to continue to deliver psychological services during the pandemic, 31 and reported to be effective in reducing stress and depression in individuals with CF and caregivers. 32 Significant disruption was also caused to important aspects of families lives such as work, education and social relationships. CYAs felt they were missing out and parents worried about the impact on their child's social and emotional development. These findings are in accordance with a recent Belgian study which also reported a significant psychological impact on CF patients due to COVID-19, albeit in the absence of specific governmental shielding guidance. 19 People with CF have an increased risk for mental health problems due to their chronic condition, and may therefore be at risk for developing further/exacerbated psychological problems during the pandemic. 13 A study that assessed the impact of shielding in the UK, on the mental wellbeing of adults with CF found that although depression levels were low and stable; anxiety levels significantly increased-however this was reported to be a normal response to an external threat (COVID- 19) , and was reported to have improved adherence to shielding. 33 Another study conducted in Turkey also found that the pandemic caused significant increase in anxiety amongst mothers of children with CF, as well as those with healthy children when compared to children with CF (13-18 years). 21 Lower anxiety scores in children with CF compared to age-matched healthy control group has also been reported elsewhere. 20 It was postulated that a potential reason for lower anxiety scores in children with CF may relate to previous exposure to stressful illness experiences, necessitating the early development of adaptive coping strategies when compared to a healthy control group who may be experiencing a serious health problem for the first time.

Both parents and CYAs reported hypervigilance of hygiene practices. 

One major strength of this study is that it is a national study using a survey that has been co-produced with both parents and CYAs. 

We would like to thank all parents and children/young adults who contributed their time and experiences to this study. To the Cystic Fibrosis Trust for sharing the information via social media and websites. We also would like to thank the Southampton Coronavirus

Response Fund for funding this study.

The authors declare that there are no conflict of interests. formal analysis (supporting); writing review and editing (supporting).

Anne-Sophie Darlington: conceptualization (lead); formal analysis (supporting); project administration (lead); writing review and editing (supporting).

Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children. ECDC: Stockholm

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Coronavirus disease 2019 in children-United States

Susceptibility to and transmission of COVID-19 amongst children and adolescents compared with adults: a systematic review and meta-analysis

Levels of stress due to the SARS-CoV-2 pandemic among parents of children with and without chronic conditions across the USA

COVID-19 and children with cancer: Parents' experiences, anxieties and support needs

WHO declares COVID-19 a pandemic

The diagnosis and management of respiratory viral infections in cystic fibrosis. Expert review of respiratory medicine. Expert review of respiratory medicine

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: an international observational study

SARS-CoV-2 (COVID-19) and cystic fibrosis

COVID-19 meets cystic fibrosis: for better or worse?

International committee on mental health in cystic fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety

Anxiety in children with cystic fibrosis and their parents: a systematic review

Rates of depression and anxiety in Italian patients with cystic fibrosis and parent caregivers: implementation of the mental health guidelines

Positive mental health and wellbeing in adults with cystic fibrosis: a cross sectional study

Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries

The lived experience of fathers caring for a child with cystic fibrosis

The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients

Effect of COVID-19 pandemic on anxiety levels of children with cystic fibrosis and healthy children

Effect of the COVID-19 pandemic on anxiety among children with cystic fibrosis and their mothers

Guidance on shielding and protecting people who are clinically extremely vulnerable from

What sample size is "enough" in internet survey research

Research methods in healthcare epidemiology: survey and qualitative research

Research Methods for Business and Management (International Ed

Metaethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia

Quest for certainty regarding early discharge in paediatric low-risk febrile neutropenia: a multicentre qualitative focus group discussion study involving patients, parents and healthcare professionals in the UK

Decision-making in childhood cancer: parents' and adolescents' views and perceptions. Supp Care Cancer

Using thematic analysis in psychology. Qualitative research in psychology

Differences in experiences of care between patients diagnosed with metastatic cancer of known and unknown primaries: mixed-method findings from the 2013 cancer patient experience survey in England

Business as usual? Psychological support at a distance

Psychological interventions during COVID pandemic: telehealth for individuals with cystic fibrosis and caregivers

The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis

Germs-and-Staying-Healthy/How-Can-You-Avoid-Germs/How-Can-You-Reduce-the-Risk

The effects of social distancing and self-isolation during the COVID-19 pandemic on adults diagnosed with asthma: a qualitative study

Exercise as a therapeutic intervention for people with cystic fibrosis

How to cite this article

COVID-19: Impact, experiences, and support needs of children and young adults with cystic fibrosis and parents

The data that support the findings of this study are available from the corresponding author upon reasonable request.

http://orcid.org/0000-0003-1398-9105